Induction of clinical and immunological responses in patients with metastatic renal cell carcinoma after vaccinations with peptide pulsed dendritic cells.

被引：0
|
作者：
Wierecky, J [1 ]
Müller, MR [1 ]
Horger, MS [1 ]
Brugger, W [1 ]
Kanz, L [1 ]
Brossart, P [1 ]
机构：
[1] Univ Tubingen, Tubingen, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：167S / 167S
页数：1
相关论文
共 50 条
  • [41] Dendritic cell immunotherapy for patients with metastatic renal cell carcinoma: University of Tokyo experience
    Azuma, T
    Horie, S
    Tomita, K
    Takahashi, T
    Tanaka, Y
    Kashiwase, K
    Nieda, M
    Takeuchi, T
    Ohta, N
    Shibata, Y
    Hirai, H
    Kitamura, T
    INTERNATIONAL JOURNAL OF UROLOGY, 2002, 9 (06) : 340 - 346
  • [42] Vaccination of advanced or relapsed esophageal cancer patients with WT1 and/or MUC1 peptide-pulsed dendritic cells induces immunological and clinical responses
    Ogasawara, M.
    Ota, S.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S115 - S116
  • [43] Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinoma
    Rieser, C
    Ramoner, R
    Höltl, L
    Rogatsch, H
    Papesh, C
    Stenzl, A
    Bartsch, G
    Thurnher, M
    UROLOGIA INTERNATIONALIS, 1999, 63 (03) : 151 - 159
  • [44] Current clinical practice of induction and maintenance immunotherapy for metastatic renal cell carcinoma
    Little, B
    Young, M
    Ho, KJ
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (01) : 36 - 39
  • [45] Allogeneic dendritic cells fused with tumor cells:: Preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma
    Märten, A
    Renoth, S
    Heinicke, T
    Albers, P
    Pauli, A
    Mey, U
    Caspari, R
    Flieger, D
    Hanfland, P
    Von Ruecker, A
    Eis-Hübinger, AM
    Müller, S
    Schwaner, I
    Lohmann, U
    Heylmann, G
    Sauerbruch, T
    Schmidt-Wolf, IGH
    HUMAN GENE THERAPY, 2003, 14 (05) : 483 - 494
  • [46] Regression of human metastatic renal cell carcinoma after vaccination with tumor cell–dendritic cell hybrids
    Alexander Kugler
    Gernot Stuhler
    Peter Walden
    Gerhard Zöller
    Anke Zobywalski
    Peter Brossart
    Uwe Trefzer
    Silke Ullrich
    Claudia A. Müller
    Volker Becker
    Andreas J. Gross
    Bernhard Hemmerlein
    Lothar Kanz
    Gerhard A. Müller
    Rolf-Hermann Ringert
    Nature Medicine, 2000, 6 : 332 - 336
  • [47] Clinical and immunological monitoring of a multi-peptide vaccination trial in patients with stage III renal cell carcinoma
    Bedke, J.
    Laske, K.
    Feyerabend, S.
    Gouttefangeas, C.
    Droege, A.
    Hennelotter, J.
    Hrstic, P.
    Stevanovic, S.
    Rammensee, H. G.
    Stenzl, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E76 - U439
  • [48] Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma
    Lau, R
    Wang, F
    Jeffery, G
    Marty, V
    Kuniyoshi, J
    Bade, E
    Ryback, ME
    Weber, J
    JOURNAL OF IMMUNOTHERAPY, 2001, 24 (01): : 66 - 78
  • [49] Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib
    Iacovelli, Roberto
    Carteni, Giacomo
    Milella, Michele
    Berardi, Rossana
    Di Lorenzo, Giuseppe
    Verzoni, Elena
    Rizzo, Mimma
    Santoni, Matteo
    Procopio, Giuseppe
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2014, 8 (3-4): : E121 - E125
  • [50] Regulatory T cells, dendritic cells and neutrophils in patients with renal cell carcinoma
    Minarik, Ivo
    Last'ovicka, Jan
    Budinsky, Vit
    Kayserova, Jana
    Spisek, Radek
    Jarolim, Ladislav
    Fialova, Anna
    Babjuk, Marek
    Bartunkova, Jirina
    IMMUNOLOGY LETTERS, 2013, 152 (02) : 144 - 150
12345